Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning.

Journal: Frontiers in immunology
PMID:

Abstract

The presence of pathogen-specific antibodies in an individual's blood-sample is used as an indication of previous exposure and infection to that specific pathogen (e.g., virus or bacterium). Measurement of the diagnostic antibodies is routinely achieved using solid phase immuno-assays such as ELISA tests and western blots. Here, we describe a sero-diagnostic approach based on phage-display of epitope arrays we term "Domain-Scan". We harness Next-generation sequencing (NGS) to measure the serum binding to dozens of epitopes derived from HIV-1 and HCV simultaneously. The distinction of healthy individuals from those infected with either HIV-1 or HCV, is modeled as a machine-learning classification problem, in which each determinant ("domain") is considered as a feature, and its NGS read-out provides values that correspond to the level of determinant-specific antibodies in the sample. We show that following training of a machine-learning model on labeled examples, we can very accurately classify unlabeled samples and pinpoint the domains that contribute most to the classification. Our experimental/computational Domain-Scan approach is general and can be adapted to other pathogens as long as sufficient training samples are provided.

Authors

  • Smadar Hada-Neeman
    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Yael Weiss-Ottolenghi
    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Naama Wagner
    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Oren Avram
    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Haim Ashkenazy
    Max Planck Institute for Developmental Biology, Max Planck Society (MPG), Tübingen, Germany.
  • Yaakov Maor
    Institute of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel.
  • Ella H Sklan
    Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Dmitry Shcherbakov
    Russian-American Anti-Cancer Center, Altai State University, Barnaul, Russia.
  • Tal Pupko
    Department of Earth and Planetary Science, UC Berkeley, Berkeley, CA, 94720, USA.
  • Jonathan M Gershoni
    The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.